nach oben

Neurological Sciences

Erschienen in:

01.08.2020 | Review Article

Different modalities of invasive neurostimulation for epilepsy

verfasst von: Soha A. Alomar, Rothaina J. Saeedi

Erschienen in: Neurological Sciences | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Epilepsy affects 1% of the general population, about one-third of which is pharmacologically resistant. Uncontrolled seizures are associated with an increased risk of traumatic injury and sudden unexpected death of epilepsy. There is a considerable psychological and financial burden on caregivers of patients with epilepsy, particularly among pediatric patients. Epilepsy surgery, when indicated, is the most promising cure for epilepsy. However, when surgery is contraindicated or refused by the patient, neurostimulation is an alternative palliative approach, albeit with a lower chance of entirely curing patients of seizures. There are many options for neurostimulation. The three most commonly used invasive neurostimulation procedures that consistently show evidence of being safe and efficacious are vagal nerve stimulation, responsive neuro stimulation, or anterior thalamic nucleus deep brain stimulation. The goal of this review is to summarize the current evidence supporting the use of these three techniques, which are approved by most regulatory bodies, and discuss different factors that may enable epilepsy surgeons to choose the most appropriate modality for each patient.

Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342(5):314–319. https://doi.org/10.1056/nejm200002033420503CrossRefPubMed

Romanelli P, Conti A (2015) Neuromodulation for the treatment of drug-resistant epilepsy. Epilepsy Towards the Next Decade: New Trends and Hopes in Epileptology:213–230. doi:https://doi.org/10.1007/978-3-319-12283-0_12

Cengiz O, Atalar AÇ, Tekin B, Bebek N, Baykan B, Gürses C (2019) Impact of seizure-related injuries on quality of life. Neurol Sci 40(3):577–583. https://doi.org/10.1007/s10072-018-3697-3CrossRefPubMed

Rani A, Thomas PT (2019) Stress and perceived stigma among parents of children with epilepsy. Neurol Sci 40(7):1363–1370. https://doi.org/10.1007/s10072-019-03822-6CrossRefPubMedPubMedCentral

Duncan JS, Hamani C (2015) Stimulating the brain for epilepsy. Neurology 84(8):768–769. https://doi.org/10.1212/wnl.0000000000001297CrossRefPubMed

Schulze-Bonhage A (2019) Long-term outcome in neurostimulation of epilepsy. Epilepsy Behav 91:25–29. https://doi.org/10.1016/j.yebeh.2018.06.011CrossRefPubMed

Devinsky O, Hesdorffer DC, Thurman DJ, Lhatoo S, Richerson G (2016) Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol 15(10):1075–1088. https://doi.org/10.1016/s1474-4422(16)30158-2CrossRefPubMed

Cooper IS, Upton ARM (1978) Use of chronic cerebellar stimulation for disorders of disinhibition. Lancet 311(8064):595–600. https://doi.org/10.1016/S0140-6736(78)91038-3CrossRef

Sramka M, Fritz G, Galanda M, Nadvornik P (1976) Some observations in treatment stimulation of epilepsy. Acta Neurochir (23 Suppl):257-262. doi:https://doi.org/10.1007/978-3-7091-8444-8_41

10.

Benabid AL, Minotti L, Koudsie A, de Saint MA, Hirsch E (2002) Antiepileptic effect of high-frequency stimulation of the subthalamic nucleus (corpus luysi) in a case of medically intractable epilepsy caused by focal dysplasia: a 30-month follow-up: technical case report. Neurosurgery 50(6):1385–1391; discussion 1391-1382. https://doi.org/10.1097/00006123-200206000-00037CrossRefPubMed

11.

Halpern CH, Samadani U, Litt B, Jaggi JL, Baltuch GH (2008) Deep brain stimulation for epilepsy. Neurotherapeutics 5(1):59–67. https://doi.org/10.1016/j.nurt.2007.10.065CrossRefPubMedPubMedCentral

12.

Yang D, Wang Q, Xu C, Fang F, Fan J, Li L, Du Q, Zhang R, Wang Y, Lin Y, Huang Z, Wang H, Chen C, Xu Q, Wang Y, Zhang Y, Zhang Z, Zhao X, Zhao X, Li T, Liu C, Niu Y, Zhou Q, Zhou Q, Duan Y, Liu X, Yu T, Xue Q, Li J, Dai X, Han J, Ren C, Xu H, Li N, Zhang J, Xu N, Yang K, Wang Y (2020) Transcranial direct current stimulation reduces seizure frequency in patients with refractory focal epilepsy: a randomized, double-blind, sham-controlled, and three-arm parallel multicenter study. Brain Stimul 13(1):109–116. https://doi.org/10.1016/j.brs.2019.09.006CrossRefPubMed

13.

Borges U, Laborde S, Raab M (2019) Influence of transcutaneous vagus nerve stimulation on cardiac vagal activity: not different from sham stimulation and no effect of stimulation intensity. PLoS One 14(10):e0223848. https://doi.org/10.1371/journal.pone.0223848CrossRefPubMedPubMedCentral

14.

Yap JYY, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T (2020) Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice. Front Neurosci 14:284–284. https://doi.org/10.3389/fnins.2020.00284CrossRefPubMedPubMedCentral

15.

Keute M, Boehrer L, Ruhnau P, Heinze HJ, Zaehle T (2019) Transcutaneous vagus nerve stimulation (tVNS) and the dynamics of visual bistable perception. Front Neurosci 13:227. https://doi.org/10.3389/fnins.2019.00227CrossRefPubMedPubMedCentral

16.

Kobayashi M, Pascual-Leone A (2003) Transcranial magnetic stimulation in neurology. Lancet Neurol 2(3):145–156. https://doi.org/10.1016/s1474-4422(03)00321-1CrossRefPubMed

17.

DeGiorgio CM, Soss J, Cook IA, Markovic D, Gornbein J, Murray D, Oviedo S, Gordon S, Corralle-Leyva G, Kealey CP, Heck CN (2013) Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology 80(9):786–791. https://doi.org/10.1212/WNL.0b013e318285c11aCrossRefPubMedPubMedCentral

18.

Boon P, Vonck K, van Rijckevorsel K, El Tahry R, Elger CE, Mullatti N, Schulze-Bonhage A, Wagner L, Diehl B, Hamer H, Reuber M, Kostov H, Legros B, Noachtar S, Weber YG, Coenen VA, Rooijakkers H, Schijns OE, Selway R, Van Roost D, Eggleston KS, Van Grunderbeek W, Jayewardene AK, McGuire RM (2015) A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation. Seizure 32:52–61. https://doi.org/10.1016/j.seizure.2015.08.011CrossRefPubMed

19.

Zabara J (1992) Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 33(6):1005–1012. https://doi.org/10.1111/j.1528-1157.1992.tb01751.xCrossRefPubMed

20.

Krahl SE, Clark KB, Smith DC, Browning RA (1998) Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39(7):709–714. https://doi.org/10.1111/j.1528-1157.1998.tb01155.xCrossRefPubMed

21.

Ben-Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J, Treig T, Stefan H, Ramsay RE, Wernicke JF, Wilder BJ (1995) Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 20(3):221–227. https://doi.org/10.1016/0920-1211(94)00083-9CrossRefPubMed

22.

Ogbonnaya S, Kaliaperumal C (2013) Vagal nerve stimulator: evolving trends. J Nat Sci Biol Med 4(1):8–13. https://doi.org/10.4103/0976-9668.107254CrossRefPubMedPubMedCentral

23.

Henry TR, Bakay RA, Votaw JR, Pennell PB, Epstein CM, Faber TL, Grafton ST, Hoffman JM (1998) Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 39(9):983–990. https://doi.org/10.1111/j.1528-1157.1998.tb01448.xCrossRefPubMed

24.

Ben-Menachem E, Mañon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, Tarver WB, Wernicke JF (1994) Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 35(3):616–626. https://doi.org/10.1111/j.1528-1157.1994.tb02482.xCrossRefPubMed

25.

Group TVNSS (1995) A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The vagus Nerve Stimulation Study Group. Neurology 45(2):224–230. https://doi.org/10.1212/wnl.45.2.224CrossRef

26.

Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW (1998) Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 51(1):48–55. https://doi.org/10.1212/wnl.51.1.48CrossRefPubMed

27.

Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tinuper P, Zamponi N, Aguglia U, Wagner L, Minotti L, Stefan H, Boon P, Sadler M, Benna P, Raman P, Perucca E (2014) The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia 55(6):893–900. https://doi.org/10.1111/epi.12611CrossRefPubMedPubMedCentral

28.

El Tahry R, Hirsch M, Van Rijckevorsel K, Santos SF, de Tourtchaninoff M, Rooijakkers H, Coenen V, Schulze-Bonhage A (2016) Early experiences with tachycardia-triggered vagus nerve stimulation using the AspireSR stimulator. Epileptic Disord 18(2):155–162. https://doi.org/10.1684/epd.2016.0831CrossRefPubMed

29.

Fisher RS, Afra P, Macken M, Minecan DN, Bagić A, Benbadis SR, Helmers SL, Sinha SR, Slater J, Treiman D, Begnaud J, Raman P, Najimipour B (2016) Automatic vagus nerve stimulation triggered by ictal tachycardia: clinical outcomes and device performance--the U.S. E-37 trial. Neuromodulation 19(2):188–195. https://doi.org/10.1111/ner.12376CrossRefPubMed

30.

Hamilton P, Soryal I, Dhahri P, Wimalachandra W, Leat A, Hughes D, Toghill N, Hodson J, Sawlani V, Hayton T, Samarasekera S, Bagary M, McCorry D, Chelvarajah R (2018) Clinical outcomes of VNS therapy with AspireSR® (including cardiac-based seizure detection) at a large complex epilepsy and surgery centre. Seizure 58:120–126. https://doi.org/10.1016/j.seizure.2018.03.022CrossRefPubMed

31.

Englot DJ, Chang EF, Auguste KI (2011) Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg 115(6):1248–1255. https://doi.org/10.3171/2011.7.Jns11977CrossRefPubMed

32.

Morris GL 3rd, Mueller WM (1999) Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 53(8):1731–1735. https://doi.org/10.1212/wnl.53.8.1731CrossRefPubMed

33.

Elliott RE, Morsi A, Tanweer O, Grobelny B, Geller E, Carlson C, Devinsky O, Doyle WK Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. (1525–5069 (Electronic))

34.

Oliveira T, Francisco AN, Demartini ZJ, Stebel SL (2017) The role of vagus nerve stimulation in refractory epilepsy. Arq Neuropsiquiatr 75(9):657–666. https://doi.org/10.1590/0004-282x20170113CrossRefPubMed

35.

Hamani C, Hodaie M, Lozano AM (2005) Present and future of deep brain stimulation for refractory epilepsy. Acta Neurochir 147(3):227–229. https://doi.org/10.1007/s00701-004-0474-2CrossRefPubMed

36.

Zangiabadi N, Ladino LD, Sina F, Orozco-Hernández JP, Carter A, Téllez-Zenteno JF (2019) Deep brain stimulation and drug-resistant epilepsy: a review of the literature. Front Neurol 10:601–601. https://doi.org/10.3389/fneur.2019.00601CrossRefPubMedPubMedCentral

37.

Kotagal P (2011) Neurostimulation: vagus nerve stimulation and beyond. Semin Pediatr Neurol 18(3):186–194. https://doi.org/10.1016/j.spen.2011.06.005CrossRefPubMed

38.

Mirski MA, Fisher RS (1994) Electrical stimulation of the mammillary nuclei increases seizure threshold to pentylenetetrazol in rats. Epilepsia 35(6):1309–1316. https://doi.org/10.1111/j.1528-1157.1994.tb01803.xCrossRefPubMed

39.

Lega BC, Halpern CH, Jaggi JL, Baltuch GH (2010) Deep brain stimulation in the treatment of refractory epilepsy: update on current data and future directions. Neurobiol Dis 38(3):354–360. https://doi.org/10.1016/j.nbd.2009.07.007CrossRefPubMed

40.

Sorokin JM, Davidson TJ, Frechette E, Abramian AM, Deisseroth K, Huguenard JR, Paz JT (2017) Bidirectional control of generalized epilepsy networks via rapid real-time switching of firing mode. Neuron 93(1):194–210. https://doi.org/10.1016/j.neuron.2016.11.026CrossRefPubMed

41.

Detre JA, Alsop DC, Aguirre GK, Sperling MR (1996) Coupling of cortical and thalamic ictal activity in human partial epilepsy: demonstration by functional magnetic resonance imaging. Epilepsia 37(7):657–661. https://doi.org/10.1111/j.1528-1157.1996.tb00630.xCrossRefPubMed

42.

Yu T, Wang X, Li Y, Zhang G, Worrell G, Chauvel P, Ni D, Qiao L, Liu C, Li L, Ren L, Wang Y (2018) High-frequency stimulation of anterior nucleus of thalamus desynchronizes epileptic network in humans. Brain 141(9):2631–2643. https://doi.org/10.1093/brain/awy187CrossRefPubMed

43.

Upton AR, Amin I, Garnett S, Springman M, Nahmias C, Cooper IS (1987) Evoked metabolic responses in the limbic-striate system produced by stimulation of anterior thalamic nucleus in man. Pacing Clin Electrophysiol 10(1 Pt 2):217–225. https://doi.org/10.1111/j.1540-8159.1987.tb05952.xCrossRefPubMed

44.

Hodaie M, Wennberg RA, Dostrovsky JO, Lozano AM (2002) Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia 43(6):603–608. https://doi.org/10.1046/j.1528-1157.2002.26001.xCrossRefPubMed

45.

Andrade DM, Zumsteg D, Hamani C, Hodaie M, Sarkissian S, Lozano AM, Wennberg RA (2006) Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy. Neurology 66(10):1571–1573. https://doi.org/10.1212/01.wnl.0000206364.19772.39CrossRefPubMed

46.

Kerrigan JF, Litt B, Fisher RS, Cranstoun S, French JA, Blum DE, Dichter M, Shetter A, Baltuch G, Jaggi J, Krone S, Brodie M, Rise M, Graves N (2004) Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia 45(4):346–354. https://doi.org/10.1111/j.0013-9580.2004.01304.xCrossRefPubMed

47.

Lee KJ, Jang KS, Shon YM (2006) Chronic deep brain stimulation of subthalamic and anterior thalamic nuclei for controlling refractory partial epilepsy. Acta Neurochir Suppl 99:87–91. https://doi.org/10.1007/978-3-211-35205-2_17CrossRefPubMed

48.

Lim SN, Lee ST, Tsai YT, Chen IA, Tu PH, Chen JL, Chang HW, Su YC, Wu T (2007) Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long-term follow-up study. Epilepsia 48(2):342–347. https://doi.org/10.1111/j.1528-1167.2006.00898.xCrossRefPubMed

49.

Oh YS, Kim HJ, Lee KJ, Kim YI, Lim SC, Shon YM (2012) Cognitive improvement after long-term electrical stimulation of bilateral anterior thalamic nucleus in refractory epilepsy patients. Seizure 21(3):183–187. https://doi.org/10.1016/j.seizure.2011.12.003CrossRefPubMed

50.

Fisher R, Salanova V, Witt T, Worth R, Henry T, Gross R, Oommen K, Osorio I, Nazzaro J, Labar D, Kaplitt M, Sperling M, Sandok E, Neal J, Handforth A, Stern J, DeSalles A, Chung S, Shetter A, Bergen D, Bakay R, Henderson J, French J, Baltuch G, Rosenfeld W, Youkilis A, Marks W, Garcia P, Barbaro N, Fountain N, Bazil C, Goodman R, McKhann G, Babu Krishnamurthy K, Papavassiliou S, Epstein C, Pollard J, Tonder L, Grebin J, Coffey R, Graves N (2010) Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51(5):899–908. https://doi.org/10.1111/j.1528-1167.2010.02536.xCrossRefPubMed

51.

Salanova V, Witt T, Worth R, Henry TR, Gross RE, Nazzaro JM, Labar D, Sperling MR, Sharan A, Sandok E, Handforth A, Stern JM, Chung S, Henderson JM, French J, Baltuch G, Rosenfeld WE, Garcia P, Barbaro NM, Fountain NB, Elias WJ, Goodman RR, Pollard JR, Troster AI, Irwin CP, Lambrecht K, Graves N, Fisher R (2015) Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology 84(10):1017–1025. https://doi.org/10.1212/wnl.0000000000001334CrossRefPubMedPubMedCentral

52.

Sun FT, Morrell MJ, Wharen RE Jr (2008) Responsive cortical stimulation for the treatment of epilepsy. Neurotherapeutics 5(1):68–74. https://doi.org/10.1016/j.nurt.2007.10.069CrossRefPubMedPubMedCentral

53.

Geller EB, Skarpaas TL, Gross RE, Goodman RR, Barkley GL, Bazil CW, Berg MJ, Bergey GK, Cash SS, Cole AJ, Duckrow RB, Edwards JC, Eisenschenk S, Fessler J, Fountain NB, Goldman AM, Gwinn RP, Heck C, Herekar A, Hirsch LJ, Jobst BC, King-Stephens D, Labar DR, Leiphart JW, Marsh WR, Meador KJ, Mizrahi EM, Murro AM, Nair DR, Noe KH, Park YD, Rutecki PA, Salanova V, Sheth RD, Shields DC, Skidmore C, Smith MC, Spencer DC, Srinivasan S, Tatum W, Van Ness PC, Vossler DG, Wharen RE Jr, Worrell GA, Yoshor D, Zimmerman RS, Cicora K, Sun FT, Morrell MJ (2017) Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia 58(6):994–1004. https://doi.org/10.1111/epi.13740CrossRefPubMed

54.

Heck CN, King-Stephens D, Massey AD, Nair DR, Jobst BC, Barkley GL, Salanova V, Cole AJ, Smith MC, Gwinn RP, Skidmore C, Van Ness PC, Bergey GK, Park YD, Miller I, Geller E, Rutecki PA, Zimmerman R, Spencer DC, Goldman A, Edwards JC, Leiphart JW, Wharen RE, Fessler J, Fountain NB, Worrell GA, Gross RE, Eisenschenk S, Duckrow RB, Hirsch LJ, Bazil C, O'Donovan CA, Sun FT, Courtney TA, Seale CG, Morrell MJ (2014) Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia 55(3):432–441. https://doi.org/10.1111/epi.12534CrossRefPubMedPubMedCentral

55.

Morrell MJ (2011) Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 77(13):1295–1304. https://doi.org/10.1212/WNL.0b013e3182302056CrossRefPubMed

56.

Geller EB (2018) Responsive neurostimulation: review of clinical trials and insights into focal epilepsy. Epilepsy Behav 88s:11–20. https://doi.org/10.1016/j.yebeh.2018.06.042CrossRefPubMed

57.

Meador KJ, Kapur R, Loring DW, Kanner AM, Morrell MJ (2015) Quality of life and mood in patients with medically intractable epilepsy treated with targeted responsive neurostimulation. Epilepsy Behav 45:242–247. https://doi.org/10.1016/j.yebeh.2015.01.012CrossRefPubMed

58.

Jobst BC, Kapur R, Barkley GL, Bazil CW, Berg MJ, Bergey GK, Boggs JG, Cash SS, Cole AJ, Duchowny MS, Duckrow RB, Edwards JC, Eisenschenk S, Fessler AJ, Fountain NB, Geller EB, Goldman AM, Goodman RR, Gross RE, Gwinn RP, Heck C, Herekar AA, Hirsch LJ, King-Stephens D, Labar DR, Marsh WR, Meador KJ, Miller I, Mizrahi EM, Murro AM, Nair DR, Noe KH, Olejniczak PW, Park YD, Rutecki P, Salanova V, Sheth RD, Skidmore C, Smith MC, Spencer DC, Srinivasan S, Tatum W, Van Ness P, Vossler DG, Wharen RE Jr, Worrell GA, Yoshor D, Zimmerman RS, Skarpaas TL, Morrell MJ (2017) Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas. Epilepsia 58(6):1005–1014. https://doi.org/10.1111/epi.13739CrossRefPubMed

59.

Rolston JD, Englot DJ, Wang DD, Shih T, Chang EF (2012) Comparison of seizure control outcomes and the safety of vagus nerve, thalamic deep brain, and responsive neurostimulation: evidence from randomized controlled trials. Neurosurg Focus 32(3):E14. https://doi.org/10.3171/2012.1.Focus11335CrossRefPubMed

60.

Ma BB, Rao VR (2018) Responsive neurostimulation: candidates and considerations. Epilepsy Behav 88:388–395. https://doi.org/10.1016/j.yebeh.2018.09.032CrossRefPubMed

61.

King-Stephens D, Mirro E, Weber PB, Laxer KD, Van Ness PC, Salanova V, Spencer DC, Heck CN, Goldman A, Jobst B, Shields DC, Bergey GK, Eisenschenk S, Worrell GA, Rossi MA, Gross RE, Cole AJ, Sperling MR, Nair DR, Gwinn RP, Park YD, Rutecki PA, Fountain NB, Wharen RE, Hirsch LJ, Miller IO, Barkley GL, Edwards JC, Geller EB, Berg MJ, Sadler TL, Sun FT, Morrell MJ (2015) Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography. Epilepsia 56(6):959–967. https://doi.org/10.1111/epi.13010CrossRefPubMedPubMedCentral

62.

DiLorenzo DJ, Mangubat EZ, Rossi MA, Byrne RW (2014) Chronic unlimited recording electrocorticography-guided resective epilepsy surgery: technology-enabled enhanced fidelity in seizure focus localization with improved surgical efficacy. J Neurosurg 120(6):1402–1414. https://doi.org/10.3171/2014.1.jns131592CrossRefPubMed

63.

Rossignol E, Lortie A, Thomas T, Bouthiller A, Scavarda D, Mercier C, Carmant L (2009) Vagus nerve stimulation in pediatric epileptic syndromes. Seizure 18(1):34–37. https://doi.org/10.1016/j.seizure.2008.06.010CrossRefPubMed

64.

Assenza G, Tombini M, Lanzone J, Ricci L, Di Lazzaro V, Casciato S, Morano A, Giallonardo AT, Di Bonaventura C, Beghi E, Ferlazzo E, Gasparini S, Giuliano L, Pisani F, Benna P, Bisulli F, De Falco FA, Franceschetti S, La Neve A, Meletti S, Mostacci B, Sartucci F, Striano P, Villani F, Aguglia U, Avanzini G, Belcastro V, Bianchi A, Cianci V, Labate A, Magaudda A, Michelucci R, Verri A, Zaccara G, Pizza V, Tinuper P, Di Gennaro G, on behalf of the Epilepsy Study Group of the Italian Neurological S (2020) Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review. Neurol Sci. https://doi.org/10.1007/s10072-020-04479-2

65.

Morris GL 3rd, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C (2013) Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 81(16):1453–1459. https://doi.org/10.1212/WNL.0b013e3182a393d1CrossRefPubMedPubMedCentral

66.

Kokoszka MA, Panov F, La Vega-Talbott M, McGoldrick PE, Wolf SM, Ghatan S (2018) Treatment of medically refractory seizures with responsive neurostimulation: 2 pediatric cases. J Neurosurg Pediatr 21(4):421–427. https://doi.org/10.3171/2017.10.peds17353CrossRefPubMed

67.

Ryvlin P, Cucherat M, Rheims S (2011) Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol 10(11):961–968. https://doi.org/10.1016/s1474-4422(11)70193-4CrossRefPubMed

Titel: Different modalities of invasive neurostimulation for epilepsy
verfasst von: Soha A. Alomar
Rothaina J. Saeedi
Publikationsdatum: 01.08.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 12/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04614-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Endovascular treatment of ischemic large-vessel stroke due to infective endocarditis: case series and review of the literature

MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development

Is Covid-19 lockdown related to an increase of accesses for seizures in the emergency department? An observational analysis of a paediatric cohort in the Southern Italy

Neurological manifestations and comorbidity associated with COVID-19: an overview

Anti-LGI1 encephalitis in a middle-aged woman who consumes cannabis oil